Akero Therapeutics, Inc.

TD ASSET MANAGEMENT INC AKRO

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/10/2025

Shares

188,844

Value ($000)

8,966

Weight

0.0%

2019 Q4 - 2025 Q3 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/10/2025	8,966	0.0%	188,844	9/30/2025
2025 Q2	7/28/2025	10,216	0.0%	191,448	6/30/2025
2025 Q1	5/7/2025	8,454	0.0%	208,848	3/31/2025
2024 Q4	2/11/2025	4,720	0.0%	169,654	12/31/2024
2024 Q3	11/1/2024	3,486	0.0%	123,454	9/30/2024
2024 Q2	8/2/2024	3,627	0.0%	154,592	6/30/2024
2024 Q1	5/8/2024	3,157	0.0%	124,992	3/31/2024
2023 Q4	2/12/2024	2,200	0.0%	94,202	12/31/2023
2023 Q3	10/27/2023	6,378	0.0%	126,092	9/30/2023
2023 Q2	8/9/2023	2,930	0.0%	62,746	6/30/2023
2023 Q1	5/10/2023	2,220	0.0%	58,022	3/31/2023
2022 Q4	2/7/2023	2,873	0.0%	52,422	12/31/2022
2022 Q3	11/7/2022	570	0.0%	19,122	9/30/2022
2021 Q4	2/10/2022	531	0.0%	25,102	12/31/2021
2021 Q3	11/9/2021	561	0.0%	25,102	9/30/2021
2021 Q2	8/11/2021	538	0.0%	25,102	6/30/2021
2021 Q1	5/14/2021	728	0.0%	25,102	3/31/2021
2020 Q4	2/16/2021	506	0.0%	19,605	12/31/2020
2020 Q3	11/10/2020	480	0.0%	15,605	9/30/2020
2020 Q2	8/13/2020	217	0.0%	8,722	6/30/2020
2019 Q4	2/11/2020	229	0.0%	10,322	12/31/2019